Ludacris donated $100,000 to Iowa's ChildServe to support critical care for children who need specialized medical attention.

FDA approves FUROSCIX® for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow™ AutoinjectorWESTLAKE ...

Campfire Circle delivers camp-inspired programs to pediatric hospitals across Ontario, including London Health Sciences ...

SBS-IF is the second orphan disease target indication for Jaguar's intestinal failure program, which includes microvillus inclusion disease (MVID) - for which the company completed a meeting in ...

Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® (revumenib) was named Best New Drug at the ...

EXXUA is now available through Aytu RxConnect® pharmacies to ensure optimal access and availabilityEXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving ...

An investigation into 158 youth motocross deaths shows inconsistent safety measures cause preventable fatalities nationwide.

The chemotherapy induced anemia market offers opportunities through innovative therapies, expanding biosimilar use, and ...

Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.

With the UHN REB approval, issued through the Clinical Trials Ontario (CTO) Stream system, St. Michael’s Hospital in Toronto, Ontario will now proceed to complete operational approvals, training, and ...

This study retrospectively analyzed ten pediatric patients with HOX-driven AML who received revumenib maintenance after HSCT at a single-center. The median age was 10 years (range: 1-18). 80% (8/10) ...

Many people living with focal onset seizures (FOS) fail to achieve seizure freedom, even after taking two or more ...